Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Acquires ICOS To Bring Full Value Of Cialis In House

This article was originally published in The Pink Sheet Daily

Executive Summary

$2.1 bil. deal will allow Lilly to benefit from efficiencies in development, marketing and sales of the erectile dysfunction product.
Advertisement

Related Content

People In The News: Tracking The Latest Industry Personnel Moves
People In The News: Tracking The Latest Industry Personnel Moves
Abbott Extends Antibody Target Deal With Caprion
Abbott Extends Antibody Target Deal With Caprion
Big Splash Acquisitions Could Drive Investors Toward Biotech
Big Splash Acquisitions Could Drive Investors Toward Biotech
Erectile Dysfunction Market Rebounding After Vision Scare
Erectile Dysfunction Market Rebounding After Vision Scare
Cialis Once-A-Day Could Launch In Late 2007, ICOS Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS063206

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel